Farhad Sedarati

1.7k citations
36 papers · 1.2k indexed · h-index 16
Topics
Ubiquitin and proteasome pathways (11 papers)Protein Degradation and Inhibitors (9 papers)Acute Myeloid Leukemia Research (7 papers)

In The Last Decade

Farhad Sedarati

36 papers receiving 1.2k citations

Peers

Farhad Sedarati
Comparison fields: 5 of 84
  • Molecular Biology 641
  • Epidemiology 406
  • Oncology 319
  • Genetics 185
  • Hematology 176
Replace Lena Ångman with:
Lena Ångman Switzerland
John Marken United States
Yasuhiko Munakata Japan
Carin Szostecki Germany
Chozhavendan Rathinam United States
R Jerzy United States
Ravi Hingorani United States
Ann E. Schmierer United States
F Sigaux France
Alyce M. Oliver United States
Farhad Sedarati relative to Lena Ångman Switzerland Lena Ångman's profile →
Citations per field
00.5×1.5×2.5×
Lena Ångman · 1×
Citations per year

Countries citing papers authored by Farhad Sedarati

Since Specialization
Citations

This map shows the geographic impact of Farhad Sedarati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Sedarati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Sedarati more than expected).

Fields of papers citing papers by Farhad Sedarati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhad Sedarati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Sedarati. The network helps show where Farhad Sedarati may publish in the future.

Co-authorship network of co-authors of Farhad Sedarati

This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Sedarati. A scholar is included among the top collaborators of Farhad Sedarati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Sedarati. Farhad Sedarati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 7
3 7
4 4
5 5
6 19
7 67
8 15
9 157
10 62
11 28
12 7
13 26
14 26
15 32
16 59
17 6
18 47
19 196
20 31

About Farhad Sedarati

Farhad Sedarati is a scholar working on Hematology, Orthopedics and Sports Medicine and Cancer Research, having authored 36 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (11 papers), Protein Degradation and Inhibitors (9 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Orthopedics and Sports Medicine (146 citations), Hematology (176 citations) and Virology (64 citations). Farhad Sedarati has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include J G Stevens, Todd P. Margolis, A.T. Dobson, Jack G. Stevens, Lawrence T. Feldman, Hélène M. Faessel, Ronan Swords, Harry P. Erba, Douglas V. Faller and Michael B. Maris. Their work appears in journals such as Science, Neuron and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026